This treatment is effective for reducing attacks in relapsing-remitting multiple sclerosis and slowing disease progression and activity in secondary progressive multiple sclerosis.
While the early stages of multiple sclerosis are less discernible, the chronic stages can greatly reduce an individual's quality of life by limiting motor function.